Exparel Transversus Abdominis Plane Block vs Intrathecal Analgesia In Colorectal Surgery

• Status: Completed
• Trial end date: 2017-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is prospective, randomized trial in which EXPAREL TAP block is compared to standard IT opioid administration, in relieving postoperative pain, decreasing length of stay, and use of narcotic medication.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic
• Treatments: Bupivacaine; Hydromorphone

Criteria

Inclusion Criteria:

• • All patients undergoing elective laparoscopic or open colorectal resections who are eligible for IT

• Age >18 years

• BMI <40

• Ability to understand and read English

Exclusion Criteria:

• • Not able or unwilling to sign consent.

• Currently pregnant or lactating.

• Patients with chronic pain, requiring daily opiate use at time of surgery.

• Patients intolerant of opiates, NSAIDS, acetaminophen or local anesthetics.

• Patients requiring emergent surgery.

• Abdominoperineal resections

• Any contraindications to neuraxial analgesia (coagulopathy, localized infection at the potential site of injection, pre-existing spinal canal pathology)

• Patients with a diagnosis of inflammatory bowel disease